Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2012

01-06-2012 | IM - ORIGINAL

Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome

Authors: Francesco Angelico, Lorenzo Loffredo, Pasquale Pignatelli, Teresa Augelletti, Roberto Carnevale, Antonio Pacella, Fabiana Albanese, Ilaria Mancini, Serena Di Santo, Maria Del Ben, Francesco Violi

Published in: Internal and Emergency Medicine | Issue 3/2012

Login to get access

Abstract

The aim of this study was to assess whether adherence to a restricted-calorie, Mediterranean-type diet improves endothelial dysfunction and markers of oxidative stress in patients with metabolic syndrome. A moderately low-calorie (600 calories/day negative energy balance), low-fat, high-carbohydrate diet (<30% energy from fat, <10% from saturated fat and 55% from carbohydrate) was prescribed to 53 outpatients with the metabolic syndrome. Participants were divided into two groups according to body weight loss > or < 5% after 6 months. Group A (n = 23) showed a remarkable decrease in body weight (−6.8%), body-mass-index (−4.6%), waist circumference (−4.8%), HOMA-IR (−27.2%), plasma glucose, glycosylated haemoglobin, total and LDL-cholesterol, blood pressure, serum NOX2 (the catalytic core of NADPH oxidase) (−22.2%) and urinary8-isoprostanes (−39.0%) and an increase of serum NOx (Nitrite/Nitrate) (+116.8%) and adiponectine (+125.5%) as compared with those in group B (n = 30). A statistically significant increase in brachial artery flow-mediated dilatation was observed in group A (+24.7%; p < 0.001), while no changes were present in group B. Variations of flow-mediated dilatation were statistically and negatively correlated with changes of serum NOX2 levels (p = 0.04), body-mass-index (p < 0.01), waist circumference (0.01), glycosylated haemoglobin (p < 0.01), LDL-cholesterol (p < 0.01) and triglycerides (p < 0.05) and positively correlated with changes of serum NOx (p < 0.001) and adiponectin (p = 0.01). The results show that moderate weight loss is able to improve endothelial dysfunction in patients with the metabolic syndrome. The coexistent decrease of NOX2 activation suggests a role for oxidative stress in eliciting artery dysfunction.
Literature
1.
go back to reference (2001) Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285:2486–2497 (2001) Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285:2486–2497
2.
go back to reference Despres JP, Lemieux I, Bergeron J et al (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039–1049PubMedCrossRef Despres JP, Lemieux I, Bergeron J et al (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039–1049PubMedCrossRef
4.
go back to reference Landmesser U, Drexler H (2005) The clinical significance of endothelial dysfunction. Curr Opin Cardiol 20: 547–-551 Landmesser U, Drexler H (2005) The clinical significance of endothelial dysfunction. Curr Opin Cardiol 20: 547–-551
5.
go back to reference Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 39:257–265PubMedCrossRef Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 39:257–265PubMedCrossRef
6.
7.
go back to reference Cangemi R, Angelico F, Loffredo L et al (2007) Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 43:853–859PubMedCrossRef Cangemi R, Angelico F, Loffredo L et al (2007) Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 43:853–859PubMedCrossRef
8.
go back to reference Hamburg NM, Larson MG, Vita JA et al (2008) Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 101:82–88PubMedCrossRef Hamburg NM, Larson MG, Vita JA et al (2008) Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 101:82–88PubMedCrossRef
9.
go back to reference Joannides R, Haefeli WE, Linder L et al (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319PubMed Joannides R, Haefeli WE, Linder L et al (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319PubMed
11.
go back to reference Heiss C, Lauer T, Dejam A et al (2006) Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J Am Coll Cardiol 47:573–579PubMedCrossRef Heiss C, Lauer T, Dejam A et al (2006) Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J Am Coll Cardiol 47:573–579PubMedCrossRef
12.
go back to reference Loffredo L, Marcoccia A, Pignatelli P et al (2007) Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 28:608–612PubMedCrossRef Loffredo L, Marcoccia A, Pignatelli P et al (2007) Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 28:608–612PubMedCrossRef
13.
go back to reference Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844PubMed Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844PubMed
14.
go back to reference Violi F, Marino R, Milite MT, Loffredo L (1999) Nitric oxide and its role in lipid peroxidation. Diabetes Metab Res Rev 15:283–288PubMedCrossRef Violi F, Marino R, Milite MT, Loffredo L (1999) Nitric oxide and its role in lipid peroxidation. Diabetes Metab Res Rev 15:283–288PubMedCrossRef
15.
go back to reference Dai J, Jones DP, Goldberg J et al (2008) Association between adherence to the Mediterranean diet and oxidative stress. Am J Clin Nutr 88:1364–1370PubMed Dai J, Jones DP, Goldberg J et al (2008) Association between adherence to the Mediterranean diet and oxidative stress. Am J Clin Nutr 88:1364–1370PubMed
16.
go back to reference Rallidis LS, Lekakis J, Kolomvotsou A et al (2009) Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity. Am J Clin Nutr 90:263–268PubMedCrossRef Rallidis LS, Lekakis J, Kolomvotsou A et al (2009) Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity. Am J Clin Nutr 90:263–268PubMedCrossRef
17.
go back to reference Forstermann U (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5:338–349PubMedCrossRef Forstermann U (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5:338–349PubMedCrossRef
18.
go back to reference Bendall JK, Rinze R, Adlam D et al (2007) Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res 100:1016–1025PubMedCrossRef Bendall JK, Rinze R, Adlam D et al (2007) Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res 100:1016–1025PubMedCrossRef
19.
go back to reference Oelze M, Warnholtz A, Faulhaber J et al (2006) NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice. Arterioscler Thromb Vasc Biol 26:1753–1759PubMedCrossRef Oelze M, Warnholtz A, Faulhaber J et al (2006) NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice. Arterioscler Thromb Vasc Biol 26:1753–1759PubMedCrossRef
20.
go back to reference Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP (2004) gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109:1795–1801PubMedCrossRef Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP (2004) gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109:1795–1801PubMedCrossRef
21.
go back to reference Violi F, Sanguigni V, Carnevale R et al (2009) Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 120:1616–1622PubMedCrossRef Violi F, Sanguigni V, Carnevale R et al (2009) Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 120:1616–1622PubMedCrossRef
22.
go back to reference Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef
23.
go back to reference Wang Z, Ciabattoni G, Creminon C et al (1995) Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 275:94–100PubMed Wang Z, Ciabattoni G, Creminon C et al (1995) Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 275:94–100PubMed
24.
go back to reference Pignatelli P, Carnevale R, Cangemi R et al (2010) Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30:360–367PubMedCrossRef Pignatelli P, Carnevale R, Cangemi R et al (2010) Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30:360–367PubMedCrossRef
25.
go back to reference Fortuno A, Bidegain J, Robador PA et al (2009) Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension. Hypertension 54:744–750PubMedCrossRef Fortuno A, Bidegain J, Robador PA et al (2009) Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension. Hypertension 54:744–750PubMedCrossRef
26.
go back to reference Fito M, Guxens M, Corella D et al (2007) Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med 167:1195–1203PubMedCrossRef Fito M, Guxens M, Corella D et al (2007) Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med 167:1195–1203PubMedCrossRef
27.
go back to reference Shai I, Schwarzfuchs D, Henkin Y et al (2008) Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359:229–241PubMedCrossRef Shai I, Schwarzfuchs D, Henkin Y et al (2008) Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359:229–241PubMedCrossRef
28.
go back to reference Sacks FM, Bray GA, Carey VJ et al (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360:859–873PubMedCrossRef Sacks FM, Bray GA, Carey VJ et al (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360:859–873PubMedCrossRef
29.
go back to reference Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM (2008) Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 87:567–576PubMed Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM (2008) Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 87:567–576PubMed
30.
go back to reference Keogh JB, Brinkworth GD, Clifton PM (2007) Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. Br J Nutr 98:852–859PubMedCrossRef Keogh JB, Brinkworth GD, Clifton PM (2007) Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. Br J Nutr 98:852–859PubMedCrossRef
31.
go back to reference Williams IL, Chowienczyk PJ, Wheatcroft SB et al (2005) Endothelial function and weight loss in obese humans. Obes Surg 15:1055–1060PubMedCrossRef Williams IL, Chowienczyk PJ, Wheatcroft SB et al (2005) Endothelial function and weight loss in obese humans. Obes Surg 15:1055–1060PubMedCrossRef
32.
go back to reference Bigornia SJ, Mott MM, Hess DT et al (2010) Long-term successful weight loss improves vascular endothelial function in severely obese individuals. Obesity (Silver Spring) 18:754–759CrossRef Bigornia SJ, Mott MM, Hess DT et al (2010) Long-term successful weight loss improves vascular endothelial function in severely obese individuals. Obesity (Silver Spring) 18:754–759CrossRef
33.
go back to reference Davi G, Guagnano MT, Ciabattoni G et al (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288:2008–2014PubMedCrossRef Davi G, Guagnano MT, Ciabattoni G et al (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288:2008–2014PubMedCrossRef
34.
go back to reference Szabo C, Day BJ, Salzman AL (1996) Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett 381:82–86PubMedCrossRef Szabo C, Day BJ, Salzman AL (1996) Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett 381:82–86PubMedCrossRef
35.
go back to reference Carnevale R, Pignatelli P, Di Santo S et al (2010) Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. Atherosclerosis 213:225–234PubMedCrossRef Carnevale R, Pignatelli P, Di Santo S et al (2010) Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. Atherosclerosis 213:225–234PubMedCrossRef
36.
go back to reference Furukawa S, Fujita T, Shimabukuro M et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752–1761PubMed Furukawa S, Fujita T, Shimabukuro M et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752–1761PubMed
37.
go back to reference Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N (2005) A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54:194–199PubMedCrossRef Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N (2005) A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54:194–199PubMedCrossRef
38.
go back to reference Tao L, Gao E, Jiao X et al (2007) Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115:1408–1416PubMedCrossRef Tao L, Gao E, Jiao X et al (2007) Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115:1408–1416PubMedCrossRef
39.
go back to reference Shai I, Spence JD, Schwarzfuchs D et al (2010) Dietary intervention to reverse carotid atherosclerosis. Circulation 121:1200–1208PubMedCrossRef Shai I, Spence JD, Schwarzfuchs D et al (2010) Dietary intervention to reverse carotid atherosclerosis. Circulation 121:1200–1208PubMedCrossRef
Metadata
Title
Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome
Authors
Francesco Angelico
Lorenzo Loffredo
Pasquale Pignatelli
Teresa Augelletti
Roberto Carnevale
Antonio Pacella
Fabiana Albanese
Ilaria Mancini
Serena Di Santo
Maria Del Ben
Francesco Violi
Publication date
01-06-2012
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 3/2012
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0591-x

Other articles of this Issue 3/2012

Internal and Emergency Medicine 3/2012 Go to the issue

CE - MEDICAL ILLUSTRATION

Melanonychia secondary to hydroxyurea

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.